NOX provides update to Nyrada Note Holders  
 
    December 18 Nyrada Update  
 
    Noxopharm Releases Report on Key Progress of Subsidiary Nyrada  
 
    Noxopharm Subsidiary Nyrada Announces Important Drug Discovery  
 
    AFR 30 August 2018 : Advances in Biotech - Lower cholesterol treatment breakthrough  
 
    Nyrada- key progress with cholesterol-lowering drug candidate  
 
    Nyrada, Inc. Newsletter 2. April 2018  
 
    Nyrada,Inc. Newsletter 1. Jan/Feb 2018  
 
    Noxopharm Closes $4M Capital Raising for its US Subsidiary, Nyrada,Inc.  
 
    Identification of NYX-104, a promising lead candidate for the treatment of stroke and other excitotoxicity- associated disorders.  
 
    US biotech to develop Australian science